Codocyte
Codocyte, also known as target cell, is a type of red blood cell that has the appearance of a shooting target with a bullseye. The name "codocyte" is derived from the Greek words "kodos" meaning "target" and "kytos" meaning "cell".
Etymology[edit]
The term "codocyte" is derived from the Greek words "kodos", which means "target", and "kytos", which means "cell". The term is used to describe the appearance of these cells, which resemble a shooting target with a bullseye.
Appearance[edit]
Codocytes have a central area of hemoglobinization, or "bullseye", surrounded by a clear zone and then a peripheral ring of hemoglobinization. This appearance is due to an excess of cell membrane relative to cell volume.
Causes[edit]
Codocytes can be seen in various conditions including liver diseases, iron deficiency anemia, and thalassemia. In liver diseases, the liver is unable to properly process and remove excess cholesterol from the red blood cell membrane, leading to the formation of codocytes. In iron deficiency anemia and thalassemia, the red blood cells are smaller than normal and the excess membrane forms the characteristic target appearance.
Diagnosis[edit]
The presence of codocytes can be identified through a peripheral blood smear test. This test involves taking a sample of the patient's blood and spreading it on a glass slide. The slide is then stained and examined under a microscope. Codocytes will appear as cells with a dark center, clear middle, and dark outer ring.
Treatment[edit]
Treatment for codocytes involves addressing the underlying condition causing their formation. This may involve treating liver disease, supplementing iron in cases of iron deficiency anemia, or managing thalassemia through blood transfusions and medications.
See also[edit]
Codocyte[edit]
-
Target cells and spherocytes
-
Poikilocytes - Red blood cell types
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
